S. A. Hussain, H. Faisal, and G. K. Dy, “Prolonged disease control despite ALK inhibitor discontinuation in advanced ALK-positive NSCLC”, EJCRIM, vol. 11, no. 6, Apr. 2024, doi: 10.12890/2024_004527.